BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 2802929)

  • 21. Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives.
    Mata I; Sham PC; Gilvarry CM; Jones PB; Lewis SW; Murray RM
    Schizophr Res; 2000 Aug; 44(2):129-36. PubMed ID: 10913744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizotypy: phenotypic marker as risk factor.
    Catts SV; Fox AM; Ward PB; McConaghy N
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S101-7. PubMed ID: 11129293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients.
    Chen WJ; Liu SK; Chang CJ; Lien YJ; Chang YH; Hwu HG
    Am J Psychiatry; 1998 Sep; 155(9):1214-20. PubMed ID: 9734545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity of the family history method for diagnosing schizophrenia, schizophrenia-related psychoses, and schizophrenia-spectrum personality disorders in first-degree relatives of schizophrenia probands.
    Fogelson DL; Nuechterlein KH; Asarnow RF; Payne DL; Subotnik KL
    Schizophr Res; 2004 Jun; 68(2-3):309-17. PubMed ID: 15099612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial aggregation of schizotypy in schizophrenia-spectrum disorders and its relation to clinical and neurodevelopmental characteristics.
    Soler J; Ferentinos P; Prats C; Miret S; Giralt M; Peralta V; Fañanás L; Fatjó-Vilas M
    J Psychiatr Res; 2017 Jan; 84():214-220. PubMed ID: 27764693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schizotypal personality disorder in parents and the risk for schizophrenia in siblings.
    Kendler KS; Walsh D
    Schizophr Bull; 1995; 21(1):47-52. PubMed ID: 7770740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The kings schizotypy questionnaire as a quantitative measure of schizophrenia liability.
    Jones LA; Cardno AG; Murphy KC; Sanders RD; Gray MY; McCarthy G; McGuffin P; Owen MJ; Williams J
    Schizophr Res; 2000 Oct; 45(3):213-21. PubMed ID: 11042439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia.
    Kendler KS; Thacker L; Walsh D
    Schizophr Bull; 1996; 22(3):511-20. PubMed ID: 8873301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temperament and character dimensions of the relatives of schizophrenia patients and controls: the relationship between schizotypal features and personality.
    Bora E; Veznedaroglu B
    Eur Psychiatry; 2007 Jan; 22(1):27-31. PubMed ID: 17129710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls.
    Esterberg ML; Jones EM; Compton MT; Walker EF
    Schizophr Res; 2007 Dec; 97(1-3):6-13. PubMed ID: 17897810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of vulnerability among first-degree relatives of patients with schizophrenia.
    Solanki RK; Swami MK; Singh P; Gupta S
    East Asian Arch Psychiatry; 2012 Sep; 22(3):118-25. PubMed ID: 23019286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modern research criteria and the genetics of schizophrenia.
    Baron M; Gruen R; Kane J; Asnis L
    Am J Psychiatry; 1985 Jun; 142(6):697-701. PubMed ID: 4003588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.
    Compton MT; Chien VH; Bollini AM
    Psychiatr Q; 2009 Sep; 80(3):143-54. PubMed ID: 19396546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia.
    Baron M; Gruen R; Rainer JD; Kane J; Asnis L; Lord S
    Am J Psychiatry; 1985 Apr; 142(4):447-55. PubMed ID: 3976917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vulnerability to schizophrenia: neuropsychological performance and schizotypal personality traits].
    Laurent A; Halim V; Sechier P; Daumal M; Foussard N; Dumas P; Daléry J; d'Amato T
    Encephale; 2001; 27(2):173-9. PubMed ID: 11407270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Structured Interview for Schizotypy (SIS): a preliminary report.
    Kendler KS; Lieberman JA; Walsh D
    Schizophr Bull; 1989; 15(4):559-71. PubMed ID: 2623438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizotypal dimensions: continuity between schizophrenia and bipolar disorders.
    Schürhoff F; Laguerre A; Szöke A; Méary A; Leboyer M
    Schizophr Res; 2005 Dec; 80(2-3):235-42. PubMed ID: 16169190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study.
    Kendler KS; McGuire M; Gruenberg AM; Walsh D
    Am J Psychiatry; 1995 May; 152(5):755-64. PubMed ID: 7726316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A family study of DSM-III-R schizoaffective disorder, depressive type, compared with schizophrenia and psychotic and nonpsychotic major depression.
    Maj M; Starace F; Pirozzi R
    Am J Psychiatry; 1991 May; 148(5):612-6. PubMed ID: 2018162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent validation of schizotaxia: a pilot study.
    Stone WS; Faraone SV; Seidman LJ; Green AI; Wojcik JD; Tsuang MT
    Biol Psychiatry; 2001 Sep; 50(6):434-40. PubMed ID: 11566160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.